CDI ONEVIEW PROCESSING CORE

The Department of Veterans Affairs, through its Network Contracting Office 10 in Dayton, Ohio, is pursuing a sole-source acquisition for the CDI OneView Processing Core and associated components under solicitation number 36C25026Q0599, with a response deadline of June 5, 2026. This action is justified under FAR 13.106(b)(1)(i) due to the proprietary nature of Terumo Cardiovascular Systems Corporation’s CDI OneView Monitoring System, which is integrated into existing clinical workflows at the Cleveland Veterans Affairs Medical Center and cannot be substituted by any other vendor without compromising patient safety, procedural continuity, and system compatibility during cardiopulmonary bypass procedures. The procurement includes nine distinct components—three each of the Processing Core, touchscreen displays, BPM modules, H/S probes, calibrators, and mounting brackets—as well as calibration gases and full clinical installation services, all of which must be sourced exclusively from Terumo. Delivery is scheduled within 60 days of order placement at the Cleveland, Ohio facility, with inspection and acceptance occurring on-site by VA personnel following installation by authorized Terumo technicians. No pricing data is provided, and the estimated contract value remains unspecified, consistent with the intent-to-sole-source nature of this notice. The contract imposes strict performance conditions including mandatory installation and technical support only by Terumo-authorized representatives, prohibition of third-party servicing, and full compatibility with existing perfusion equipment. No small business set-aside applies, and Terumo is inferred to be other than small under NAICS 334510, as no viable alternatives meet the proprietary system requirements. There are no contract options, no cost or pricing details disclosed, and no formal evaluation factors or award criteria because competition is precluded. Submission of responses must be emailed to Rachelle Hamer by the stated deadline, with no alternative submission methods permitted, and no packaging, marking, accounting codes, invoicing protocols, or COR/COTR assignments are detailed in the documentation. The system’s operational integrity, clinical safety, and manufacturer-specific compatibility are the sole benchmarks for acceptance, with no reference to external standards such as ISO or FDA requirements, making Terumo’s proprietary specifications the governing technical baseline for compliance.